- Home
- TELA vs NTRB Comparison
TELA vs NTRB Comparison
Compare TELA & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- NTRB
- Stock Information
- Founded
- TELA 2012
- NTRB 2016
- Country
- TELA United States
- NTRB United States
- Employees
- TELA N/A
- NTRB N/A
- Industry
- TELA Medical/Dental Instruments
- NTRB Industrial Specialties
- Sector
- TELA Health Care
- NTRB Health Care
- Exchange
- TELA Nasdaq
- NTRB Nasdaq
- Market Cap
- TELA 70.1M
- NTRB 71.8M
- IPO Year
- TELA 2019
- NTRB N/A
- Fundamental
- Price
- TELA $1.62
- NTRB $6.39
- Analyst Decision
- TELA Buy
- NTRB Buy
- Analyst Count
- TELA 3
- NTRB 1
- Target Price
- TELA $5.33
- NTRB $13.00
- AVG Volume (30 Days)
- TELA 106.3K
- NTRB 36.9K
- Earning Date
- TELA 11-06-2025
- NTRB 09-05-2025
- Dividend Yield
- TELA N/A
- NTRB N/A
- EPS Growth
- TELA N/A
- NTRB N/A
- EPS
- TELA N/A
- NTRB N/A
- Revenue
- TELA $75,323,000.00
- NTRB $2,398,437.00
- Revenue This Year
- TELA $25.72
- NTRB $560.75
- Revenue Next Year
- TELA $22.03
- NTRB $588.39
- P/E Ratio
- TELA N/A
- NTRB N/A
- Revenue Growth
- TELA 16.34
- NTRB 18.92
- 52 Week Low
- TELA $0.86
- NTRB $2.98
- 52 Week High
- TELA $3.26
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- TELA 44.30
- NTRB 42.80
- Support Level
- TELA $1.56
- NTRB $5.81
- Resistance Level
- TELA $1.87
- NTRB $6.59
- Average True Range (ATR)
- TELA 0.16
- NTRB 0.31
- MACD
- TELA -0.01
- NTRB 0.05
- Stochastic Oscillator
- TELA 18.00
- NTRB 66.74
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.